Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
COPD incidence in OSAS patients (overlap syndrome) and differences between groups Source: Eur Respir J 2005; 26: Suppl. 49, 566s Year: 2005
Retrospective review of studies shows that patients receiving salmeterol plus ICS have fewer serious asthma exacerbations vs patients on ICS alone, regardless of ethnic origin Source: Eur Respir J 2005; 26: Suppl. 49, 429s Year: 2005
SARS-Cov-2 infection in asthma patients treated with biologics Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021
Significant percentage of asthma patients failed to achieve control in the first year after initiating medium or high dose ICS/LABA Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease Year: 2017
Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Treatment complication rates in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation Year: 2020
The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
Montelukast induces better control of symptoms and management of lung function, and decreased inflammation in women compared with men. Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019
A prospective study to detect ICIs’ associated Myocarditis, among patients treated for lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Comparison of demographics in quitters compared to continued smokers in patients with lung cancer Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Differences in migrating neutrophils from patients with COPD compared with healthy smokers and non smokers and patients with alpha 1 antitrypsin deficiency Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019
Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017
Lymphopenia is linked to an increased incidence of cancer in smokers without COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Exacerbation rates of COPD in hospital patients, population based cases and controls Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021